| Name | Company | P/L % | MPV | 
                                |
|---|---|---|---|---|
| Lord Glendonbrook | 
                                                         | 
                                                                                                Stryker / NYQ:SYK | 431.52% | £372,062.83 | 
| Lord Glendonbrook | 
                                                         | 
                                                                                                Abbott Laboratories / NYQ:ABT | 393.42% | £345,397.27 | 
| Lord Sassoon | 
                                                         | 
                                                                                                Abbott Laboratories / NYQ:ABT | 278.94% | £265,255.30 | 
| Lord Grabiner | 
                                                         | 
                                                                                                Boston Scientific / NYQ:BSX | 138.22% | £166,757.37** | 
| Baroness Noakes | 
                                                         | 
                                                                                                Smith & Nephew / NYQ:SNN | 70.49% | £119,344.77 | 
| Lord Glendonbrook | 
                                                         | 
                                                                                                Smith & Nephew / NYQ:SNN | 58.24% | £110,767.32 | 
| Lord Mance | 
                                                         | 
                                                                                                Stryker / NYQ:SYK | 34.17% | £93,922.18 | 
| Lord Londesborough | 
                                                         | 
                                                                                                Abbott Laboratories / NYQ:ABT | 14.57% | £80,195.73 | 
| Lord Glendonbrook | 
                                                         | 
                                                                                                Medtronic / NYQ:MDT | 10.66% | £77,463.33** | 
| Lord Howard of Rising | 
                                                         | 
                                                                                                Ekf Diagnostics / LSE:EKF.L | 4.16% | £72,910.25 | 
| Lord Browne of Madingley | Allurion / NYQ:ALUR | -44.71% | £38,700.91 | |
| Lord Glendonbrook | 
                                                         | 
                                                                                                Align Technology / NMS:ALGN | -49.43% | £35,397.62 | 
| Lord Kakkar | Cyte / NMS:CTKB | -55.35% | £31,251.50** |